Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
Clinical trial NCT06085079 · UNKNOWN
Trial details
- NCT number
- NCT06085079
- Sponsor
- Massachusetts Eye Research and Surgery Institution
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.